-
Subject Areas on Research
-
"Me-too" products--friend or foe?
-
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis.
-
Antibiotic resistance: what is the impact of agricultural uses of antibiotics on children's health?
-
Antibiotics exposure and risk of inflammatory bowel disease: a systematic review.
-
Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020.
-
Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.
-
Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure.
-
Chlamydia pneumoniae and acute coronary syndrome.
-
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens.
-
Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.
-
Community-Acquired Pneumonia in Adults: Diagnosis and Management.
-
Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones.
-
Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.
-
Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation.
-
Effects of a Collaborative, Community Hospital Network for Antimicrobial Stewardship Program Implementation.
-
Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study.
-
Emergence of fluoroquinolone resistance among Bacteroides species.
-
Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
-
Epithelial wound healing after cataract surgery comparing two different topical fluoroquinolones.
-
Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience.
-
Fluoroquinolone-based versus β-lactam-based regimens for complicated intra-abdominal infections: a meta-analysis of randomised controlled trials.
-
Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains.
-
Glucose homeostasis abnormalities associated with use of gatifloxacin.
-
History of antibiotics: from fluoroquinolones to daptomycin (Part 2).
-
Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals.
-
Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.
-
Methicillin-resistant Staphylococcus aureus (MRSA) pediatric tympanostomy tube otorrhea.
-
Moxifloxacin-induced torsades de pointes.
-
Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
-
Open Waste Canals as Potential Sources of Antimicrobial Resistance Genes in Aerosols in Urban Kanpur, India.
-
Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.
-
Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.
-
Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.
-
Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.
-
Provider and patient drivers of ototopical antibiotic prescription variability.
-
Quinolones for community-acquired pneumonia.
-
Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.
-
Reducing Fluoroquinolone Use and Clostridioides difficile Infections in Community Nursing Homes Through Hospital-Nursing Home Collaboration.
-
Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
-
Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.
-
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
-
The Use of Systemic and Topical Fluoroquinolones.
-
Torsades de pointes associated with fluoroquinolones.
-
[Chiral separation of enantiomers of pazufloxacin by capillary electrophoresis].